Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 1, 2014, Pages 40-50

  Liu, Xiangde ^a   Nelson, Amy ^a   Wang, Xingqi ^a   Farid, Maha ^a   Gunji, Yoko ^a   Ikari, Jun ^a   Iwasawa, Shun ^a   Basma, Hesham ^a   Feghali Bostwick, Carol ^b   Rennard, Stephen I ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Fibroblasts; PGE2; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLLAGEN GEL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FIBRONECTIN; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VITAMIN D RECEPTOR;

ADULT; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DEGRADATION; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; FETUS LUNG; FIBROBLAST CULTURE; GEL MOBILITY SHIFT ASSAY; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MODULATION; PROTEIN EXPRESSION; TISSUE REPAIR;

CELL NUCLEUS; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DNA-BINDING PROTEINS; FIBROBLASTS; FIBRONECTINS; HUMANS; INTERLEUKIN-1BETA; LUNG; PROTEIN TRANSPORT; RECEPTORS, CALCITRIOL; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITAMIN D;

EID: 84891792186     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0211OC     Document Type: Article

References (34)

1. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009; 179: 630-636.
2. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med 2010; 181: 699-704.
3. Chishimba L, Thickett DR, Stockley RA, Wood AM. The vitamin D axis in the lung: a key role for vitamin d-binding protein. Thorax 2010; 65: 456-462.
4. Liu N, Nguyen L, Chun RF, Lagishetty V, Ren S, Wu S, Hollis B, DeLuca HF, Adams JS, Hewison M. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 2008; 149: 4799-4808.
5. McMahon L, Schwartz K, Yilmaz O, Brown E, Ryan LK, Diamond G. Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect Immun 2011; 79: 2250-2256.
6. Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol 2006; 248: 149-159.
7. Peng X, Hawthorne M, Vaishnav A, St-Arnaud R, Mehta RG. 25- hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res Treat 2009; 113: 31-41.
8. Peng X, Vaishnav A, Murillo G, Alimirah F, Torres KE, Mehta RG. Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J Cell Biochem 2010; 110: 1324-1333.
9. Rennard SI, Wachenfeldt K. Rationale and emerging approaches for targeting lung repair and regeneration in the treatment of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2011; 8: 368-375.
10. Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, Kawasaki S, Ahn Y, Fredriksson K, Skold CM, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008; 178: 248-260.
11. Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, Wang X, Kim M, Li Y, Sun J, Michalski J, et al. Reduced miR-146a increases prostaglandin e(2)in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 2010; 182: 1020-1029.
12. Dagouassat M, Gagliolo JM, Chrusciel S, Bourin MC, Duprez C, Caramelle P, Boyer L, Hue S, Stern JB, Validire P, et al. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 2013; 187: 703-714.
13. Stumm CL, Wettlaufer SH, Jancar S, Peters-Golden M. Airway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2011; 301: L636-L644.
14. Dackor RT, Cheng J, Voltz JW, Card JW, Ferguson CD, Garrett RC, Bradbury JA, DeGraff LM, Lih FB, Tomer KB, et al. Prostaglandin e(2) protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction. Am J Physiol Lung Cell Mol Physiol 2011; 301: L645-L655.
15. Borok Z, Gillissen A, Buhl R, Hoyt RF, Hubbard RC, Ozaki T, Rennard SI, Crystal RG. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis 1991; 144: 1080-1084.
16. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters- Golden M. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin e2 and to express cyclooxygenase-2. J Clin Invest 1995; 95: 1861-1868.
17. Pilewski JM, Liu L, Henry AC, Knauer AV, Feghali-Bostwick CA. Insulinlike growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol 2005; 166: 399-407. (Pubitemid 40189037)
18. Liu X, Kohyama T, Wang H, Zhu YK, Wen FQ, Kim HJ, Romberger DJ, Rennard SI. Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. Am J Physiol Lung Cell Mol Physiol 2002; 282: L1049-L1056. (Pubitemid 34654622)
19. Kobayashi T, Liu X, Wen FQ, Fang Q, Abe S, Wang XQ, Hashimoto M, Shen L, Kawasaki S, Kim HJ, et al. Smad3 mediates tgf-beta1 induction of vegf production in lung fibroblasts. Biochem Biophys Res Commun 2005; 327: 393-398. (Pubitemid 40040489)
20. Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S. 25- hydroxyvitamin D3 1alpha-hydroxylase and vitamin d synthesis. Science 1997; 277: 1827-1830.
21. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 2004; 215: 31-38. (Pubitemid 38333240)
22. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third national health and nutrition examination survey. Arch Intern Med 2009; 169: 384-390.
23. Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, Eschmann R, Bals R. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011; 12: 31.
24. Gilbert CR, Arum SM, Smith CM. Vitamin D deficiency and chronic lung disease. Can Respir J 2009; 16: 75-80.
25. Kunisaki KM, Niewoehner DE, Connett JE. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med 2012; 185: 286-290.
26. Greiling D, Thieroff-Ekerdt R. 1alpha,25-dihydroxyvitamin d3 rapidly inhibits fibroblast-induced collagen gel contraction. J Invest Dermatol 1996; 106: 1236-1241. (Pubitemid 26195848)
27. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zugel U, Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 2010; 118: 142-150.
28. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008; 88: 582S-586S.
29. Shephard RM, Deluca HF. Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25- hydroxyvitamin D3 intakes. Arch Biochem Biophys 1980; 202: 43-53. (Pubitemid 11128265)
30. Krishnan AV, Moreno J, Nonn L, Swami S, Peehl DM, Feldman D. Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity. J Bone Miner Res 2007; 22: V74-V80. (Pubitemid 351304654)
31. Delgado-Martinez AD, Martinez ME, Carrascal MT, Rodriguez-Avial M, Munuera L. Effect of 25-oh-vitamin D on fracture healing in elderly rats. J Orthop Res 1998; 16: 650-653. (Pubitemid 29021893)
32. Barreto AM, Schwartz GG, Woodruff R, Cramer SD. 25-hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 2000; 9: 265-270. (Pubitemid 30165438)
33. Lou YR, Molnar F, Perakyla M, Qiao S, Kalueff AV, St-Arnaud R, Carlberg C, Tuohimaa P. 25-hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 2010; 118: 162-170.
34. Lou YR, Laaksi I, Syvala H, Blauer M, Tammela TL, Ylikomi T, Tuohimaa P. 25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. FASEB J 2004; 18: 332-334.